Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Feb 04 2021

· Issued by Zydus Lifesciences Limited

Filed with NSE · · 3 pages · English

Release

Cadila Healthcare Limited has informed the Exchange regarding a press release dated February 04, 2021, titled "Zydus announces completion of Phase-I trials of ZY19489 A single dose cure for Malaria in collaboration with MMV".

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases